Merck Announces Sale of Consumer Care Business to Bayer AG …
WEBMay 6, 2014 · its Merck Consumer Care (MCC) business to Bayer AG (BAYRY) for $14.2 billion. Under the terms of the agreement, Bayer AG will acquire Merck’s existing OTC business, including the global trademark and prescription rights for Claritin® and Afrin®. The company also announced a worldwide clinical development
Bayer acquires Merck’s consumer healthcare business for $14.2bn
WEBMay 6, 2014 · Germany’s Bayer has agreed to buy Merck ’s consumer healthcare business for $14.2bn, acquiring brands including Coppertone sunscreen lotion and Claritin anti-allergy pills in the latest deal to...
Bayer to Purchase Merck's Consumer Division - Yahoo Finance
WEBMay 7, 2014 · German HealthCare giant Bayer entered into a definitive agreement with Merck & Co. Inc. to acquire the latter’s consumer care business for $14.2 billion (€10.4 billion). The companies also ...
Merck Completes Sale of Consumer Care Business to Bayer AG …
WEBOct 1, 2014 · Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today it has completed the previously announced sale of the Merck. Consumer Care (MCC) business to Bayer AG. Effective today, Bayer will. acquire Merck’s existing over-the-counter business, including the global.
Bayer to acquire Merck’s consumer care business for $14.2bn
WEBMay 6, 2014 · German chemical and pharmaceutical company Bayer has entered into a definitive agreement to acquire the consumer care business of US-based Merck for $14.2bn. Under the terms of the agreement, Bayer will acquire Merck’s existing over-the-counter (OTC) business, including the global trademark and …
Merck and Bayer’s Investigational Drug Vericiguat Meets Primary ...
WEBNov 18, 2019 · Vericiguat Reduced the Risk of Heart Failure Hospitalization or Cardiovascular Death in Patients with Worsening Chronic Heart Failure with Reduced Ejection Fraction, Compared to Placebo When Added to Available Heart Failure Therapies.
Bayer wins Merck & Co's $14 billion consumer unit auction
WEBMay 6, 2014 · Germany's Bayer AG has trumped rival bidders for Merck & Co Inc's consumer care business in a $14.2 billion deal, adding to a string of major cross-border deals in the healthcare industry.
Bayer and Merck in $14.2B consumer deal - Yahoo Finance
WEBMay 6, 2014 · Bayer (XETRA:BAYN-DE) will acquire the consumer care business of U.S.-based Merck & Co (NYSE: MRK - News) for $14.2 billion in cash, the company said in a statement Tuesday.
Bayer to buy Merck consumer business for $14.2B | AP News
WEBMay 6, 2014 · The $14.2 billion deal announced Tuesday would vault Bayer AG atop the nonprescription medicine business across North and Latin America. It would make Bayer No. 1 worldwide in skin and gastrointestinal products, a strong No. 2 in the huge cold and allergy category, and No. 3 in pain relievers.
Merck Sells Consumer Care to Bayer for $14.2B
WEBMay 6, 2014 · Merck, known as MSD outside the United States and Canada, announces that it has entered into a definitive agreement to sell its Merck Consumer Care (MCC) business to Bayer AG (BAYRY) for $14.2 billion.
Skip to content